Vimarsana
Biggest News Aggregation in the World

Live Ignite News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Live Ignite. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Live Ignite Today - Breaking & Trending Today

AbbVie Presents Data from Extensive Portfolio at the American College of Rheumatology Convergence 2022 - Vimarsana News

AbbVie Presents Data from Extensive Portfolio at the American College of Rheumatology Convergence 2022

Published: November 8, 2022

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it would present new data across its rheumatology portfolio, including RINVOQ® (upadacitinib) for...

Source: prnewswire.com
Related Topics:
United StatesMcinnesi RisankizumabCeline GoldbergerBoehringer IngelheimAmerican College Of RheumatologyExchange CommissionAbbvie IncAmerican CollegeRheumatoid ArthritisResults ThroughConventional SyntheticResource UtilizationEconomic BurdenInadequate ResponsesAdvanced TherapiesDemonstrates Long Term Efficacy Across SubgroupsActive Psoriatic ArthritisPost HocIntegrated AnalysisPsa PatientsSecond Line TherapeuticDisease Control After DiscontinuationFirst LineSpondylarthritis RegistryNon Radiographic Axial Spondyloarthritis
AbbVie Presents Data from Extensive Portfolio at the American College of Rheumatology Convergence 2022 - Vimarsana News

AbbVie Presents Data from Extensive Portfolio at the American College of Rheumatology Convergence 2022

Published: November 8, 2022

Thirty-six abstracts underscore AbbVie's commitment to advancing research to help more people living with rheumatic diseasesAdditional analysis of...

Source: businessinsider.com
Related Topics:
United StatesMcinnesi RisankizumabCeline GoldbergerBoehringer IngelheimAmerican College Of RheumatologyExchange CommissionAbbvie IncAmerican CollegeRheumatoid ArthritisResource UtilizationEconomic BurdenDemonstrates Long Term Efficacy Across SubgroupsPsa PatientsSecond Line TherapeuticDisease Control After DiscontinuationNon Radiographic Axial SpondyloarthritisCycling Among Tumor Necrosis Factor InhibitorsUpadacitinib Clinical Trial ProgramsLive IgniteImportant SafetyMedication GuideConsumer Brief SummaryMississippi RiverPregnancy RegistryFull Prescribing Information